Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the ...

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. (ZBH) on Twitter by QuestforYield. In this article, we will ...

Here, the company is highlighting advancements in hip, knee, and upper extremity reconstruction, as well as its latest ambulatory surgery center (ASC) solutions. At AAOS 2025, Zimmer Biomet is ...

The Oxford Partial Knee ... surgery. For a full list of product indications, contraindications and warnings, please see the associated product Instructions For Use (IFU). Zimmer Biomet is a ...

Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities ... In addition, Zimmer Biomet is debuting ZBX™, its new Ambulatory Surgery Center (ASC) offering to ...